Marisé Borja joins GAB Consulting team as Head of Biopesticides and Spain Director

Date:03-15-2019

GAB Consulting, one of the largest European Regulatory Consultancy Company in Europe and part of the Group Acceres, is pleased to announce an important new addition to its leadership team: Dr. Marisé Borja has been the appointed new Head of Biopesticides and Spain Director. 

As Head of Biopesticides, Dr Marisé Borja will lead the Biopesticide team with overall program management, agreements and quality assurance responsibilities. As part of GAB Consulting’s leadership team, she will also help in setting the overall direction and strategy, in order to further promote GAB’s innovation and service excellence. She will also be responsible for driving, identifying and developing new business opportunities, and expanding the company’s capabilities.

Dr Marisé Borja has wide experience in the agricultural field, is knowledgeable about biopesticides and efficacy trials worldwide in multiple crops and brings 33 years of agronomic and Regulatory expertise to GAB Consulting and Acceres. She is an associate professor in Biochemistry and molecular biology at the Universidad Complutense de Madrid (UCM) as well as a European Union Commission and FAO Expert. Dr. Marisé Borja received her B.Sc. in Biology at the UCM and her Ph.D. in Genetics at the Instituto Nacional de Investigaciones Agrarias. She spent 5 years as a researcher in University of California Berkeley, before joining the Centro Nacional de Biotecnología in Spain. She then moved into business, becoming Head of Research and Development at Biomiva and since 2011, Chief Technology Officer at PlantResponse™. Dr. Borja is an author of over 50 research publications and over 12 issued patents and pending patent applications.

“Dr Marisé Borja is a strong addition to the company, and we are pleased to welcome her to the team. Everyone at GAB Consulting is very excited to have this new leadership, and we all look forward to her contribution to expand further beyond our great Biopesticides capabilities.” says Yvonnick Jambon, CEO of Acceres.